| Literature DB >> 27793646 |
Wasun Chantratita1, Keum-Soo Song2, Choi GunHo3, Viroj Pongthanapisith4, Nipa Thongbaiphet5, Garanyuta Wongtabtim6, Ekawat Pasomsub7, Kanokwan Angkanavin8, Satish Balasaheb Nimse9, Mukesh Digambar Sonawane10, Shrikant Dasharath Warkad11, Taisun Kim12.
Abstract
In this article, we describe the 6 HCV Genotyping 9G test and its evaluation by using clinical samples and plasmid DNA standards. In tests with 981 plasmid DNA standards, the 6 HCV Genotyping 9G test showed higher than 92.5% sensitivity and 99.4% specificity. The 6 HCV Genotyping 9G test was compared with the VERSANT HCV Genotype 2.0 assay (LiPA 2.0) for detection and discrimination of HCV genotypes in clinical samples. The results of both tests were verified by genomic sequencing. The 6 HCV Genotyping 9G test demonstrated a 100% agreement with the sequencing results, which was higher than LiPA 2.0. These results indicate that the 6 HCV Genotyping 9G test can be a reliable, sensitive, and accurate diagnostic tool for the correct identification of HCV genotypes in clinical specimens. 6 HCV Genotyping 9G test can genotype six HCV types in 1 PCR in 30min after PCR amplification. The 6 HCV Genotyping 9G test, thus provide critical information to physicians and assist them to apply accurate drug regimen for the effective hepatitis C treatment. Copyright ÂEntities:
Keywords: 9G DNA technology; HCV genotyping; Hcv; Hepatocellular carcinoma; LiPA 2.0; Liver cirrhosis
Mesh:
Substances:
Year: 2016 PMID: 27793646 DOI: 10.1016/j.jviromet.2016.10.009
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014